These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29692583)

  • 21. Experience of buffy coat pooling of platelets as a supportive care in thrombocytopenic dengue patients: A prospective study.
    Chatterjee K; Coshic P; Borgohain M; Agarwal N
    Asian J Transfus Sci; 2014 Jul; 8(2):89-91. PubMed ID: 25161345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Platelet Transfusion on Clot Strength in Dengue Fever with Thrombocytopenia Related Bleeding: A Thromboelastography-Based Study.
    Sundar V; Bhaskar E
    Transfus Med Hemother; 2019 Dec; 46(6):457-460. PubMed ID: 31933577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The behavior of transfused platelets in dengue hemorrhagic fever.
    Isarangkura P; Tuchinda S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():222-4. PubMed ID: 7886581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-yield platelet concentrates attainable by continuous quality improvement reduce platelet transfusion cost and donor exposure.
    Kelley DL; Fegan RL; Ng AT; Kennedy MK; Blanda E; Chambers LA; Kennedy MS; Lasky LC
    Transfusion; 1997 May; 37(5):482-6. PubMed ID: 9149771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
    Mair B; Benson K
    Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and laboratory factors underlying refractoriness to platelet transfusions.
    Friedberg RC
    J Clin Apher; 1996; 11(3):143-8. PubMed ID: 8915819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets.
    O'Rafferty C; Rooney G; Hagan R; Woolfson M; O'Donghaile D; Fitzgerald J
    Transfus Med; 2017 Oct; 27 Suppl 5():369-374. PubMed ID: 28393455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet transfusion. Current techniques, remaining problems, and future prospects.
    Herman JH; Kamel HT
    Am J Pediatr Hematol Oncol; 1987; 9(3):272-86. PubMed ID: 3314551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelets transfusion in Greece: Where, when, why? A national survey.
    Valsami S; Pouliakis A; Gavalaki M; Argyrou A; Triantafillou E; Arvanitopoulou E; Girtovitis F; Voulgaridou V; Megalou A; Chronopoulou P; Papachronis A; Sakellarakis G; Zervou E; Batsi C; Fountouli K; Athanasopoulos A; Kyriakou E; Cheropoulou A; Livada A; Lebessopoulos K; Papakonstantinou M; Gafou A; Katopi D; Martinis G; Dendrinou I; Katharopoulou H; Politou M; Papadopoulou M; Papadopoulou P; Manaka E; Paneta K; Alepi C; Damaskos C; Garmpis N; Stamoulis K; Grouzi E
    Asian J Transfus Sci; 2020; 14(2):158-166. PubMed ID: 33767543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and laboratory characteristics of patients with dengue hemorrhagic fever manifestations and their transfusion profile.
    Fujimoto DE; Koifman S
    Rev Bras Hematol Hemoter; 2014 Mar; 36(2):115-20. PubMed ID: 24790536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial.
    Lye DC; Archuleta S; Syed-Omar SF; Low JG; Oh HM; Wei Y; Fisher D; Ponnampalavanar SSL; Wijaya L; Lee LK; Ooi EE; Kamarulzaman A; Lum LC; Tambyah PA; Leo YS
    Lancet; 2017 Apr; 389(10079):1611-1618. PubMed ID: 28283286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased platelet:RBC ratios are associated with improved survival after massive transfusion.
    Holcomb JB; Zarzabal LA; Michalek JE; Kozar RA; Spinella PC; Perkins JG; Matijevic N; Dong JF; Pati S; Wade CE; ; Holcomb JB; Wade CE; Cotton BA; Kozar RA; Brasel KJ; Vercruysse GA; MacLeod JB; Dutton RP; Hess JR; Duchesne JC; McSwain NE; Muskat PC; Johannigamn JA; Cryer HM; Tillou A; Cohen MJ; Pittet JF; Knudson P; DeMoya MA; Schreiber MA; Tieu BH; Brundage SI; Napolitano LM; Brunsvold ME; Sihler KC; Beilman GJ; Peitzman AB; Zenati MS; Sperry JL; Alarcon LH; Croce MA; Minei JP; Steward RM; Cohn SM; Michalek JE; Bulger EM; Nunez TC; Ivatury RR; Meredith JW; Miller PR; Pomper GJ; Marin B
    J Trauma; 2011 Aug; 71(2 Suppl 3):S318-28. PubMed ID: 21814099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of an educational program to promote the use of pooled instead of single-donor platelet transfusions.
    Burch M; Schneider R; Barakat A; Abushahin L; Cao Y; Ewing J; Stone MJ
    Proc (Bayl Univ Med Cent); 2013 Jan; 26(1):3-5. PubMed ID: 23382598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of PEG-rhuMGDF in platelet apheresis.
    Kuter DJ
    Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of high dose of steroid on plateletcount in acute stage of dengue Fever with thrombocytopenia.
    Shashidhara KC; Murthy KA; Gowdappa HB; Bhograj A
    J Clin Diagn Res; 2013 Jul; 7(7):1397-400. PubMed ID: 23998074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
    Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
    Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes of prophylactic platelet transfusion in patients with dengue: A retrospective study of patients at a tertiary care hospital in Karachi.
    Sethi SM; Khalil A; Naseem Khan MR; Khatri A; ; Muhammad AJ; Murtaza G
    J Pak Med Assoc; 2017 Sep; 67(9):1374-1378. PubMed ID: 28924277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.